Vilin Bio Med EV/EBITDA Ratio

Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio

The Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Vilin Bio Med Ltd's valuation, profitability, and overall financial performance. Tracking the Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Vilin Bio Med Ltd (NSE: VILINBIO, BSE: 78871) is currently trading at ₹36.65, with a market capitalization of ₹521.03M. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio Current Value

The current Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio stands at 0.

The Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio remains stable, indicating consistent financial performance.

Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

The decline in Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.

What Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Vilin Bio Med Ltd.

Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Vilin Bio Med Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.